Article
WT1-guided pre-emptive therapy after allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia
2023-12-29
Abstract excerpt
The prognosis of patients with acute myeloid leukemia (AML) relapsing after allogeneic hematopoietic stem cell transplantation (HCT) is poor. Several studies have evaluated the significance of pre-emptive therapies using measurable residual disease (MRD) as a marker of hematological relapse. This single-center retrospective study aimed to clarify the significance of pre-emptive treatment based on Wilms’ tumor gene...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- cd81d9ff-0631-5203-8d46-ea3cf9dfa516
- DOI
- 10.21203/rs.3.rs-3743328/v1
